Please assess the completion status of the following clinical trial:

Trial Title: Procalcitonin in Fever of Unknown Etiology

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. All hospitalized patients admitted to general medical or GRM wards with fever and no obvious source of infection, and~2. remain febrile after 72 hours of empiric, antimicrobial therapy, and~3. initial blood cultures are negative.~Exclusion Criteria:~1. Patients with clinically suspected infection (strongly suggestive symptoms, signs or laboratory/imaging studies) such as pneumonia, urinary tract infection, meningitis, endocarditis, skin and soft tissue infection, etc.~2. Confirmed bacterial, viral or fungal infection (positive stain, culture or serology from appropriate clinical specimen).~3. Hypotension (systolic blood pressure \<90mmHg)~4. Respiratory failure (oxygen requirement \> 4L/min via nasal canula)~5. Patients admitted to intensive care unit.~6. Severely immunocompromised patients: (febrile neutropenia, HIV infection with CD4 count \< 200, immuno-suppressive therapy).~7. Patients younger than 21.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).